NVONovo Nordisk A/S
Healthcare · Drug Manufacturers - GeneralNYSEStockMkt cap $200.6B
Disclosed trades
59
0 in 30d · 3 in 90d
Politicians
15
Last trade Sep 10, 2026
Buys
36
$950K at range midpoints
Sells
23
$925.5K at range midpoints
Closing price · 365 days
Nov 6, 2025 – Nov 5, 2026
Monthly buys vs sells · 24 months
Counts of disclosed transactions
- Buys
- Sells (incl. partial)
Politicians who traded it
9 hold it now Estimated
| Politician | Seat | Trades | Buys | Sells | Bought (mid) | Sold (mid) | Last trade | Est. position Estimated |
|---|---|---|---|---|---|---|---|---|
| RMichael T. McCaul | House · TX-10 | 18 | 12 | 6 | $660K | $231K | Jun 27, 2025 | $111K |
| RLisa C. McClain | House · MI-09 | 7 | 3 | 4 | $24K | $32K | Oct 31, 2025 | — |
| RScott Franklin | House · FL-18 | 7 | 7 | 0 | $105K | $0 | Aug 26, 2026 | $76.7K |
| DRo Khanna | House · CA-17 | 6 | 4 | 2 | $32K | $16K | Mar 13, 2026 | $19.4K |
| RByron Donalds | House · FL-19 | 4 | 2 | 2 | $16K | $16K | Mar 20, 2025 | $4.2K |
| DKatherine M. Clark | House · MA-05 | 3 | 2 | 1 | $16K | $8K | Sep 16, 2021 | $11.7K |
| RMarjorie Taylor Greene | House · GA-14 | 3 | 3 | 0 | $48.5K | $0 | Oct 15, 2025 | $35.3K |
| DDaniel S. Goldman | House · NY-10 | 2 | 0 | 2 | $0 | $550K | Jul 12, 2023 | — |
| RJohn James | House · MI-10 | 2 | 1 | 1 | $8K | $8K | Sep 4, 2024 | $790 |
| RKevin Hern | House · OK-01 | 2 | 0 | 2 | $0 | $16K | Sep 10, 2026 | — |
| RAlan Armstrong | Senate · OK | 1 | 1 | 0 | $32.5K | $0 | Mar 30, 2026 | $37.1K |
| RLaurel M. Lee | House · FL-15 | 1 | 0 | 1 | $0 | $8K | May 8, 2025 | — |
| DMikie Sherrill | House · NJ-11 | 1 | 0 | 1 | $0 | $8K | Feb 20, 2020 | — |
| RTommy Tuberville | Senate · AL | 1 | 0 | 1 | $0 | $32.5K | Jan 19, 2024 | — |
| DVal T. Hoyle | House · OR-04 | 1 | 1 | 0 | $8K | $0 | Oct 29, 2024 | $2.9K |
Option trades on NVO
| Member | Trade | Type | Strike | Expiry | Contracts | Amount (disclosed) | Traded | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| DRo Khanna | Buy | call | $117.50 | Mar 8, 2024 | — | $1,001 - $15,000 | Mar 8, 2024 | expired | FilingOCR |
| DRo Khanna | Buy | call | $107 | Feb 9, 2024 | — | $1,001 - $15,000 | Feb 9, 2024 | expired | FilingOCR |
| DRo Khanna | Buy | call | $18 | Sep 8, 2023 | — | $1,001 - $15,000 | Sep 8, 2023 | expired | FilingOCR |
| DRo Khanna | Buy | call | $157.50 | — | — | $1,001 - $15,000 | May 12, 2023 | — | FilingOCR |
Recent trades
| Politician | Ticker | Asset | Type | Owner | Amount | vs S&P Estimated | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|---|
| RKevin Hern | NVO | Novo Nordisk A/S Common Stock (NVO) | Sell | Self | $1,001 - $15,000 | -8.8% | Sep 10, 2026 | Sep 25, 202615d | Filing |
| RKevin Hern | NVO | Novo Nordisk A/S Common Stock (NVO) | Partial | Self | $1,001 - $15,000 | -8.8% | Aug 31, 2026 | Sep 25, 202625d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | -2.8% | Aug 26, 2026 | Sep 17, 202622d | Filing |
| RAlan Armstrong | NVO | Novo Nordisk A/S Common Stock | Buy | Self | $15,001 - $50,000 | -16.3% | Mar 30, 2026 | Jul 21, 2026113d | Filing |
| DRo Khanna | NVO | NOVO-NORDISK A/S ADR ADR CMN | Buy | Spouse | $1,001 - $15,000 | -2.0% | Mar 13, 2026 | Apr 7, 202625d | FilingOCR |
| DRo Khanna | NVO | NOVO-NORDISK A/S ADR ADR CMN | Buy | Spouse | $1,001 - $15,000 | -6.8% | Feb 13, 2026 | Mar 9, 202624d | FilingOCR |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Sell | Spouse | $1,001 - $15,000 | +26.6% | Oct 31, 2025 | Nov 21, 202521d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Spouse | $1,001 - $15,000 | -26.6% | Oct 30, 2025 | Nov 21, 202522d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Sell | Spouse | $1,001 - $15,000 | +26.6% | Oct 30, 2025 | Nov 21, 202522d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Spouse | $1,001 - $15,000 | -34.3% | Sep 11, 2025 | Oct 22, 202541d | Filing |
| RMarjorie Taylor Greene | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | -36.9% | Oct 15, 2025 | Oct 20, 20255d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Partial | Spouse | $1,001 - $15,000 | +38.1% | Aug 4, 2025 | Sep 12, 202539d | Filing |
| DVal T. Hoyle | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Spouse | $1,001 - $15,000 | -38.1% | Oct 29, 2024 | Sep 12, 2025318d | Filing |
| RMarjorie Taylor Greene | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | -42.3% | Aug 28, 2025 | Aug 29, 20251d | Filing |
| RMarjorie Taylor Greene | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $15,001 - $50,000 | -40.7% | Aug 19, 2025 | Aug 20, 20251d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Spouse | $1,001 - $15,000 | -34.6% | Aug 4, 2025 | Aug 14, 202510d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | -34.6% | Aug 4, 2025 | Aug 14, 202510d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | -34.6% | Aug 4, 2025 | Aug 14, 202510d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $15,001 - $50,000 | -34.6% | Aug 4, 2025 | Aug 14, 202510d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Partial | Spouse | $1,001 - $15,000 | +34.5% | Jul 10, 2025 | Aug 13, 202534d | Filing |
| RLisa C. McClain | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Spouse | $1,001 - $15,000 | -34.5% | Jun 9, 2025 | Aug 13, 202565d | Filing |
| RMichael T. McCaul | NVO | NOVO NORdISK A S AdR | Sell | Spouse | $50,001 - $100,000 | +60.0% | Jun 27, 2025 | Jul 7, 202510d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | Sell | Spouse | $15,001 - $50,000 | +60.0% | Jun 16, 2025 | Jul 7, 202521d | FilingOCR |
| RLaurel M. Lee | NVO | Novo Nordisk A/S Common Stock (NVO) | Partial | Spouse | $1,001 - $15,000 | +64.3% | May 8, 2025 | Jun 22, 202545d | Filing |
| RByron Donalds | NVO | Novo Nordisk A/S Common Stock (NVO) | Sell | Spouse | $1,001 - $15,000 | +75.0% | Mar 20, 2025 | Apr 14, 202525d | Filing |
| RByron Donalds | NVO | Novo Nordisk A/S Common Stock (NVO) | Sell | Self | $1,001 - $15,000 | +75.0% | Mar 20, 2025 | Apr 14, 202525d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $15,001 - $50,000 | -75.0% | Mar 27, 2025 | Apr 11, 202515d | Filing |
| RScott Franklin | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | -75.0% | Mar 27, 2025 | Apr 11, 202515d | Filing |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | Buy | Dependent | $15,001 - $50,000 | -75.1% | Dec 23, 2024 | Jan 15, 202523d | FilingOCR |
| RMichael T. McCaul | NVO | NOVo NoRdISK A S AdR | Buy | Spouse | $15,001 - $50,000 | -75.1% | Dec 23, 2024 | Jan 15, 202523d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORdISK A S ADR | Sell | Dependent | $15,001 - $50,000 | +83.5% | Nov 19, 2024 | Dec 16, 202427d | FilingOCR |
| RMichael T. McCaul | NVO | NoVo NoRdIsK A S AdR | Sell | Spouse | $50,001 - $100,000 | +83.5% | Nov 19, 2024 | Dec 16, 202427d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | BuyReview | Dependent | $15,001 - $50,000 | -85.2% | Oct 31, 2024 | Nov 12, 202412d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | BuyReview | Spouse | $15,001 - $50,000 | -85.2% | Oct 31, 2024 | Nov 12, 202412d | FilingOCR |
| RByron Donalds | NVO | Novo-Nordisk As Adr (NVO) | BuyReview | Spouse | $1,001 - $15,000 | -84.9% | Oct 7, 2022 | Nov 8, 2024763d | FilingOCR |
| RByron Donalds | NVO | Novo-Nordisk As Adr (NVO) | BuyReview | Self | $1,001 - $15,000 | -84.9% | Oct 7, 2022 | Nov 8, 2024763d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | Sell | Self | $1,001 - $15,000 | +100.8% | Aug 26, 2024 | Sep 16, 202421d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORdISK A S AdR | SellReview | Spouse | $1,001 - $15,000 | +100.8% | Aug 26, 2024 | Sep 16, 202421d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | Buy | Spouse | $15,001 - $50,000 | -100.8% | Aug 9, 2024 | Sep 16, 202438d | FilingOCR |
| RJohn James | NVO | Novo Nordisk A/S Common Stock (NVO) | Sell | Self | $1,001 - $15,000 | +104.9% | Sep 4, 2024 | Sep 6, 20242d | Filing |
| RJohn James | NVO | Novo Nordisk A/S Common Stock (NVO) | Buy | Self | $1,001 - $15,000 | -103.2% | Nov 10, 2023 | Sep 2, 2024297d | Filing |
| DRo Khanna | NVO | NOVO-NORDISK A/S ADR ADR CMN | Partial | Spouse | $1,001 - $15,000 | +107.5% | Jul 12, 2024 | Aug 7, 202426d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | Buy | Dependent | $15,001 - $50,000 | -106.8% | May 29, 2024 | Jun 13, 202415d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | Buy | Spouse | $15,001 - $50,000 | -106.8% | May 28, 2024 | Jun 13, 202416d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | Buy | Dependent | $15,001 - $50,000 | -106.8% | May 6, 2024 | Jun 13, 202438d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK AS ADR | BuyReview | Unknown | $50,001 - $100,000 | -110.3% | Apr 24, 2024 | May 11, 202417d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | BuyReview | Unknown | $50,001 - $100,000 | -110.3% | Apr 24, 2024 | May 11, 202417d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK A S ADR | Buy | Dependent | $50,001 - $100,000 | -110.3% | Apr 23, 2024 | May 11, 202418d | FilingOCR |
| RMichael T. McCaul | NVO | NOVO NORDISK AS ADR | BuyReview | Unknown | $100,001 - $250,000 | -110.3% | Apr 23, 2024 | May 11, 202418d | FilingOCR |
| DRo Khanna | NVO | NOVO-NORDISK A/S ADR ADR CMN | Sell | Spouse | $1,001 - $15,000 | +111.5% | Feb 9, 2024 | Mar 6, 202426d | FilingOCR |
Unusual activity Estimated
- 41Hindsight movePublic Oct 13, 2026 · traded Aug 31, 2026
NVO fell 16% in the 30 trading days after Rep. Kevin Hern's partial sale (hindsight)
Details
- Politician
- Kevin Hern
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock (NVO)
- Tx type
- partial_sale
- Traded
- Aug 31, 2026
- Filed
- Sep 25, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 25
- Owner type
- self
- Is whale
- No
- Entry date
- Aug 31, 2026
- Entry close
- 45.33
- Exit date
- Oct 13, 2026
- Exit close
- 38.06
- Forward return
- -16.0%
- Sign adjusted return
- +16.0%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Oct 13, 2026
- Method version
- 2026-11-03
- 58Hindsight movePublic Jul 21, 2026 · traded Mar 30, 2026
NVO rose 33% in the 30 trading days after Sen. Alan Armstrong's buy (hindsight)
Details
- Politician
- Alan Armstrong
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock
- Tx type
- buy
- Traded
- Mar 30, 2026
- Filed
- Jul 21, 2026
- Amount low
- $15,001
- Amount high
- $50,000
- Range midpoint (estimate)
- $32,501
- Disclosed range
- $15,001 - $50,000
- Reporting lag days
- 113
- Owner type
- self
- Is whale
- No
- Entry date
- Mar 30, 2026
- Entry close
- 35.29
- Exit date
- May 12, 2026
- Exit close
- 47
- Forward return
- +33.2%
- Sign adjusted return
- +33.2%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Jul 21, 2026
- Method version
- 2026-11-03
- 43Committee overlapPublic Jul 21, 2026 · traded Mar 30, 2026
Sen. Alan Armstrong bought $15,001–$50,000 of NVO while sitting on Senate Health
Details
- Committee
- Senate Committee on Health, Education, Labor, and Pensions
- Leadership seat
- No
- Sector
- Healthcare
- Disclosed range
- $15,001 - $50,000
- Traded
- Mar 30, 2026
- Filed
- Jul 21, 2026
- Public from
- Jul 21, 2026
- Method version
- 2026-11-03
- 42Hindsight movePublic Sep 16, 2025 · traded Aug 4, 2025
NVO rose 17% in the 30 trading days after Rep. Scott Franklin's spouse's buy (hindsight)
Details
- Politician
- Scott Franklin
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock (NVO)
- Tx type
- buy
- Traded
- Aug 4, 2025
- Filed
- Aug 14, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 10
- Owner type
- spouse
- Is whale
- No
- Entry date
- Aug 4, 2025
- Entry close
- 48.81
- Exit date
- Sep 16, 2025
- Exit close
- 57.20
- Forward return
- +17.2%
- Sign adjusted return
- +17.2%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Sep 16, 2025
- Method version
- 2026-11-03
- 42Hindsight movePublic Sep 16, 2025 · traded Aug 4, 2025
NVO rose 17% in the 30 trading days after Rep. Scott Franklin's buy (hindsight)
Details
- Politician
- Scott Franklin
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock (NVO)
- Tx type
- buy
- Traded
- Aug 4, 2025
- Filed
- Aug 14, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 10
- Owner type
- self
- Is whale
- No
- Entry date
- Aug 4, 2025
- Entry close
- 48.81
- Exit date
- Sep 16, 2025
- Exit close
- 57.20
- Forward return
- +17.2%
- Sign adjusted return
- +17.2%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Sep 16, 2025
- Method version
- 2026-11-03
- 42Hindsight movePublic Sep 16, 2025 · traded Aug 4, 2025
NVO rose 17% in the 30 trading days after Rep. Scott Franklin's buy (hindsight)
Details
- Politician
- Scott Franklin
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock (NVO)
- Tx type
- buy
- Traded
- Aug 4, 2025
- Filed
- Aug 14, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 10
- Owner type
- self
- Is whale
- No
- Entry date
- Aug 4, 2025
- Entry close
- 48.81
- Exit date
- Sep 16, 2025
- Exit close
- 57.20
- Forward return
- +17.2%
- Sign adjusted return
- +17.2%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Sep 16, 2025
- Method version
- 2026-11-03
- 42Hindsight movePublic Sep 16, 2025 · traded Aug 4, 2025
NVO rose 17% in the 30 trading days after Rep. Scott Franklin's buy (hindsight)
Details
- Politician
- Scott Franklin
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock (NVO)
- Tx type
- buy
- Traded
- Aug 4, 2025
- Filed
- Aug 14, 2025
- Amount low
- $15,001
- Amount high
- $50,000
- Range midpoint (estimate)
- $32,501
- Disclosed range
- $15,001 - $50,000
- Reporting lag days
- 10
- Owner type
- self
- Is whale
- No
- Entry date
- Aug 4, 2025
- Entry close
- 48.81
- Exit date
- Sep 16, 2025
- Exit close
- 57.20
- Forward return
- +17.2%
- Sign adjusted return
- +17.2%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Sep 16, 2025
- Method version
- 2026-11-03
- 47Hindsight movePublic Aug 21, 2025 · traded Jul 10, 2025
NVO fell 22% in the 30 trading days after Rep. Lisa C. McClain's spouse's partial sale (hindsight)
Details
- Politician
- Lisa C. McClain
- Ticker
- NVO
- Asset
- Novo Nordisk A/S Common Stock (NVO)
- Tx type
- partial_sale
- Traded
- Jul 10, 2025
- Filed
- Aug 13, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 34
- Owner type
- spouse
- Is whale
- No
- Entry date
- Jul 10, 2025
- Entry close
- 71.01
- Exit date
- Aug 21, 2025
- Exit close
- 55.45
- Forward return
- -21.9%
- Sign adjusted return
- +21.9%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Aug 21, 2025
- Method version
- 2026-11-03
- 52Hindsight movePublic Aug 11, 2025 · traded Jun 27, 2025
NVO fell 27% in the 30 trading days after Rep. Michael T. McCaul's spouse's sale (hindsight)
Details
- Politician
- Michael T. McCaul
- Ticker
- NVO
- Asset
- NOVO NORdISK A S AdR
- Tx type
- sell
- Traded
- Jun 27, 2025
- Filed
- Jul 7, 2025
- Amount low
- $50,001
- Amount high
- $100K
- Range midpoint (estimate)
- $75,001
- Disclosed range
- $50,001 - $100,000
- Reporting lag days
- 10
- Owner type
- spouse
- Is whale
- No
- Entry date
- Jun 27, 2025
- Entry close
- 68.51
- Exit date
- Aug 11, 2025
- Exit close
- 49.87
- Forward return
- -27.2%
- Sign adjusted return
- +27.2%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Aug 11, 2025
- Method version
- 2026-11-03
- 60Hindsight movePublic Jul 30, 2025 · traded Jun 16, 2025
NVO fell 35% in the 30 trading days after Rep. Michael T. McCaul's spouse's sale (hindsight)
Details
- Politician
- Michael T. McCaul
- Ticker
- NVO
- Asset
- NOVO NORDISK A S ADR
- Tx type
- sell
- Traded
- Jun 16, 2025
- Filed
- Jul 7, 2025
- Amount low
- $15,001
- Amount high
- $50,000
- Range midpoint (estimate)
- $32,501
- Disclosed range
- $15,001 - $50,000
- Reporting lag days
- 21
- Owner type
- spouse
- Is whale
- No
- Entry date
- Jun 16, 2025
- Entry close
- 77.02
- Exit date
- Jul 30, 2025
- Exit close
- 50.03
- Forward return
- -35.0%
- Sign adjusted return
- +35.0%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Jul 30, 2025
- Method version
- 2026-11-03